Literature DB >> 31265253

Untargeted Metabolite Mapping in 3D Cell Culture Models Using High Spectral Resolution FT-ICR Mass Spectrometry Imaging.

Lulu H Tucker1, Gregory R Hamm2, Rebecca J E Sargeant2, Richard J A Goodwin2, C Logan Mackay1, Colin J Campbell1, David J Clarke1.   

Abstract

Multicellular tumor spheroids (MTS) are a well-established model system for drug development and are a valuable in vitro research tool for use prior to employing animal models. These 3D-cell cultures are thought to display chemical gradients of oxygen and nutrients throughout their structure, giving rise to distinct microenvironments in radial layers, thus, mimicking the pathophysiological environment of a tumor. Little is known about the localized distributions of metabolites within these microenvironments. To address this, here we utilize high spectral resolution Fourier-transform ion cyclotron resonance (FT-ICR), MALDI mass spectrometry imaging (MSI) to image the distribution of endogenous metabolites in breast cancer MCF-7 spheroids. We show that known specific metabolite markers (adenosine phosphates and glutathione) indicate that the central region of these cell culture models experiences increased hypoxic and oxidative stress. By using discriminatory analysis, we have identified which m/z values localize toward the outer proliferative or central hypoxic regions of an MTS. Elemental formulae were assigned with sub-ppm mass accuracy, allowing metabolite assignment. Using this information, we have mapped these metabolites back to distinct pathways to improve our understanding of the molecular environment and biochemistry of these tumor models.

Entities:  

Year:  2019        PMID: 31265253     DOI: 10.1021/acs.analchem.9b00661

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  6 in total

1.  Complement Factor H Displays Opposite Expression Patterns Under Two Situations of Methamphetamine Administration: Acute Exposure and Chronic Dependence.

Authors:  Ming Lin; Jiamin Xu; Zhimin Liu; Liang Qin; Xiaodong Wang; Xiaoping Pu
Journal:  Neurosci Bull       Date:  2020-09-07       Impact factor: 5.203

2.  Developing a Drug Screening Platform: MALDI-Mass Spectrometry Imaging of Paper-Based Cultures.

Authors:  Fernando Tobias; Julie C McIntosh; Gabriel J LaBonia; Matthew W Boyce; Matthew R Lockett; Amanda B Hummon
Journal:  Anal Chem       Date:  2019-12-06       Impact factor: 6.986

3.  Mass spectrometry imaging-based metabolomics to visualize the spatially resolved reprogramming of carnitine metabolism in breast cancer.

Authors:  Chenglong Sun; Fukai Wang; Yang Zhang; Jinqian Yu; Xiao Wang
Journal:  Theranostics       Date:  2020-05-30       Impact factor: 11.556

4.  Metabolomic analysis and mass spectrometry imaging after neonatal stroke and cell therapies in mouse brains.

Authors:  Emi Tanaka; Yuko Ogawa; Ritsuko Fujii; Tomomi Shimonaka; Yoshiaki Sato; Takashi Hamazaki; Tokiko Nagamura-Inoue; Haruo Shintaku; Masahiro Tsuji
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

5.  Characterization of an Aggregated Three-Dimensional Cell Culture Model by Multimodal Mass Spectrometry Imaging.

Authors:  Lucy E Flint; Gregory Hamm; Joseph D Ready; Stephanie Ling; Catherine J Duckett; Neil A Cross; Laura M Cole; David P Smith; Richard J A Goodwin; Malcolm R Clench
Journal:  Anal Chem       Date:  2020-08-14       Impact factor: 6.986

Review 6.  [Mass spectrometry imaging technology and its application in breast cancer research].

Authors:  Mengting Zhang; Yulu Zhang; Haojiang Wang; Ning Li; Bo Li; Hong Xiao; Wei Bian; Zongwei Cai
Journal:  Se Pu       Date:  2021-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.